COVID: SARS-CoV-2 detected in semen; and correction to dapagliflozin blog
A recent Chinese study found the presence of SARS-CoV-2 in the semen of male patients with Covid-19 (see covid semen with virus jama2020 in dropbox, or doi:10.1001/jamanetworkopen.2020.8292).
Details:
-- 38 male patients with documented Covid-19 in the Shangqiu Municipal Hospital in China, >15yo, from jan 26 to feb 16
-- 23 of these 38 (61%) achieved clinical recovery; 15 (40%) were at the acute stage of infection
Results:
-- 6 of the 38 patients (16%) had semen positive for SARS-CoV-2:
-- 4 were at the acute stage of infection (27%)
-- 2 achieved clinical recovery from infection (9%)
-- for these 6 with positive semen: 2 were in their 20s, 2 in 30s, 1 in 40s and 1 in 50s; time since onset of symptoms: 6-16 days (mostly around 10); time since hospitalization 2-13 days; time since clinical recovery 2-3 days (but only 2 recovered); 1 (the 50yo) had urogenital disease; the 2 in their 20s had coronary heart disease and one had hypertension
-- no difference between negative and positive semen results by age, urogenital disease history, days since onset, days since hospitalization, or days since clinical recovery [though the numbers of patients was way too low to show significant differencess]
Commentary:
-- of note, they did find positive semen PCR in 2 patients who had recovered clinically from Covid-19, and these were 12 and 16 days from symptom onset
-- the finding of the SARS-CoV-2 in semen does raise the possibility of sexual transmission. And, patients should be aware of this possibility. There certainly are questions as to whether this is a real and important concern:
-- the finding of SARS-CoV-2 in the semen by PCR does not necessarily mean that it is a viable, infectious virus. These could be nonviable viral fragments that are picked up by the PCR
-- even if this were viable virus, it is unclear that there could be transmission through vaginal or rectal intercourse. There is likely a higher possibility of passage through oral sex
-- it is not clear how long the virus might be viable in the testes, where there is immune tolerance, sometimes referred to as “immune privilege“: eg see https://www.ncbi.nlm.nih.gov/pubmed/16972897. But this protected area may provide a potential for prolonged viral viability.
-- the issue is that the blood-testes/deferens/epididymis barrier is imperfect and there could well be penetration of it in the presence of systemic inflammation; and because of the relative isolation in this urogenital region from the systemic immune system, the virus could persist there longer than at other sites
-- 27 viruses have been found in semen in the presence of viremia. And many of them are not known to be sexually transmitted (see Feldman H. N Engl J Med 018; 378:1440, or https://www.nejm.org/doi/10.1056/NEJMe1803212 )
-- and, there are well-documented other modes of transmission that may occur during the setting of sex: it is clear that the SARS-CoV-2 virus can be transmitted through respiratory droplets or aerosol. And perhaps through saliva during kissing
-- virus has also been detected in stool and urine, though again it is not clear this is a viable mode of transmission
So, another study raising more questions than it answers. This was a very small study that needs to be replicated in a larger and different cohort of men. And there clearly needs to be some measure of viral viability (eg, at least growth in viral culture). it would also be useful to know if the virus could be detected/culturable in vaginal/rectal samples. But there are other important concerns:
-- is virus able to live much longer in the protected male urogenital tract, even after full clinical recovery? And how long???
-- can that turn out to be a source for prolonged spread of the virus through sexual activity well after clinical Covid-19 recovery?
-- will meds that treat the virus (if they ever happen) be able to reach these protected areas and obliterate virus there, or will there be continued cause for concern of transmission later?
-- is there evidence of virus in semen from men who are asymptomatic (presumably with lower levels of systemic inflammation), though we do not have large enough samples of asymptomatic people to know this well at this time
-- though it might be reasonable to suggest condom use at this point in those who have had Covid-19 infection, do condoms work? Can the little spike glycoproteins on the virus make tiny little holes in the condom and burrow their way out????
If you would like to be on the regular email list for upcoming blogs, please contact me at gmodest@uphams.org
to get access to all of the blogs:
1. go to http://gmodestmedblogs.blogspot.com/ to see them in reverse chronological order
2. click on 3 parallel lines top left, if you want to see blogs by category, then click on "labels" and choose a category
3. or you can just click on the magnifying glass on top right, then type in a name in the search box and get all the blogs with that name in them
please feel free to circulate this to others. also, if you send me their emails, i can add them to the list
Comments
Post a Comment
if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org